We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.58%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$25.4B
AUM Growth
+$5.58B
(+28%)
Cap. Flow
+$3.58B
Cap. Flow
% of AUM
14.09%
Top 10 Holdings %
Top 10 Hldgs %
15.16%
Holding
1,957
New
313
Increased
881
Reduced
499
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$153M |
| 2 |
Home Depot
HD
|
+$120M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$89.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$88.8M |
| 5 |
Ford
F
|
+$87.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$149M |
| 2 |
Procter & Gamble
PG
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$87.4M |
| 4 |
Intercontinental Exchange
ICE
|
+$70.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$68.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 15.33% |
| 3 | Healthcare | 13.64% |
| 4 | Financials | 12.62% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
NeoGenomics
NEO
$1.81B
| $5.44M | 0.02% |
147,567
+56,258
| +62% | +$2.09M |
|
727
Denali Therapeutics
DNLI
$3.67B
| $5.43M | 0.02% |
+151,456
| New | +$4.56M |
|
|
NBIS
728
Nebius Group N.V.
NBIS
$47.7B
| $5.42M | 0.02% |
83,142
+8,650
| +12% | +$515K |
|
729
Warner Bros
WBD
$64.6B
| $5.42M | 0.02% |
249,163
+215,252
| +635% | +$4.7M |
|
730
CareTrust REIT
CTRE
$10.2B
| $5.38M | 0.02% |
302,289
+245,800
| +435% | +$4.47M |
|
|
CCXI
731
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.38M | 0.02% |
98,131
+8,020
| +9% | +$432K |
|
|
BEAT
732
DELISTED
BioTelemetry, Inc.
BEAT
| $5.38M | 0.02% |
118,011
+44,361
| +60% | +$1.85M |
|
733
LKQ Corp
LKQ
$6.58B
| $5.38M | 0.02% |
193,820
-77,835
| -29% | -$2.29M |
|
|
COR
734
DELISTED
Coresite Realty Corporation
COR
| $5.37M | 0.02% |
45,197
+17,800
| +65% | +$2.17M |
|
735
Nu Skin
NUS
$247M
| $5.36M | 0.02% |
106,984
+48,889
| +84% | +$2.32M |
|
736
Inspire Medical Systems
INSP
$1.42B
| $5.35M | 0.02% |
41,462
-155
| -0.4% | -$17.1K |
|
|
IAA
737
DELISTED
IAA, Inc. Common Stock
IAA
| $5.34M | 0.02% |
102,622
-3,183
| -3% | -$148K |
|
738
Five Below
FIVE
$11.2B
| $5.31M | 0.02% |
41,830
-2,812
| -6% | -$320K |
|
739
Expedia Group
EXPE
$31.2B
| $5.3M | 0.02% |
57,817
-181,441
| -76% | -$16.3M |
|
740
Constellium
CSTM
$3.96B
| $5.29M | 0.02% |
673,821
+229,437
| +52% | +$1.9M |
|
741
Supernus Pharmaceuticals
SUPN
$2.68B
| $5.28M | 0.02% |
253,328
+64,655
| +34% | +$1.47M |
|
|
EGRX
742
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.26M | 0.02% |
123,920
+56,833
| +85% | +$2.49M |
|
743
Carlisle Companies
CSL
$13.6B
| $5.26M | 0.02% |
42,967
+6,866
| +19% | +$843K |
|
744
Parker-Hannifin
PH
$125B
| $5.24M | 0.02% |
25,880
+23,608
| +1,039% | +$4.64M |
|
745
Brunswick
BC
$5.19B
| $5.23M | 0.02% |
88,802
+82,100
| +1,225% | +$5.24M |
|
|
MDLA
746
DELISTED
Medallia, Inc.
MDLA
| $5.22M | 0.02% |
190,373
+25,486
| +15% | +$773K |
|
747
FormFactor
FORM
$8.11B
| $5.22M | 0.02% |
209,290
+22,027
| +12% | +$614K |
|
|
SEM
748
DELISTED
Select Medical
SEM
| $5.21M | 0.02% |
464,549
+110,164
| +31% | +$1.08M |
|
749
NVR
NVR
$17.2B
| $5.21M | 0.02% |
1,276
+838
| +191% | +$3.23M |
|
750
Marvell Technology
MRVL
$174B
| $5.18M | 0.02% |
130,508
+25,757
| +25% | +$947K |
|
Similar funds
Man Group's Q3 2020 Portfolio in Review
As of Q3 2020, Man Group held 1,957 positions worth $25.4B, up 28% from $19.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Man Group deployed $3.58B of net new capital in Q3 2020, opening 313 new positions and adding to 881 existing holdings. Its largest new stake was SS&C Technologies: 585,849 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $149M trimmed.
- Man Group's largest Q3 2020 buy was SS&C Technologies: 585,849 shares worth $35.5M.
- Man Group added most to Citigroup in Q3 2020, an estimated $153M increase.
- Man Group's biggest Q3 2020 reduction was Qualcomm, cutting an estimated $149M.
- Man Group fully exited Delta Air Lines in Q3 2020, selling an estimated $28.8M.
- Man Group's ten largest holdings make up 15% of its $25.4B portfolio in Q3 2020.
- Man Group opened 313 new positions and closed 190 in Q3 2020.
- Man Group's portfolio value rose 28% quarter-over-quarter to $25.4B.
Based on Man Group's 13F filing for Q3 2020, filed 16 Nov 2020.